Cargando…

Analysis of Nausea in Clinical Studies of Lubiprostone for the Treatment of Constipation Disorders

BACKGROUND: Lubiprostone is a ClC-2 chloride channel activator approved for the treatment of chronic idiopathic constipation (CIC) and opioid-induced constipation (OIC) in adults and irritable bowel syndrome with constipation (IBS-C) in women. Lubiprostone is generally well tolerated, with nausea be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cryer, Byron, Drossman, Douglas A., Chey, William D., Webster, Lynn, Habibi, Sepideh, Wang, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694526/ https://www.ncbi.nlm.nih.gov/pubmed/28849329 http://dx.doi.org/10.1007/s10620-017-4680-1

Ejemplares similares

Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation
por: Chang, L., et al.
Publicado: (2016)

A Randomized Study of Lubiprostone for Opioid-Induced Constipation in Patients with Chronic Noncancer Pain
por: Cryer, Byron, et al.
Publicado: (2014)

Effects of Lubiprostone, an Intestinal Secretagogue, on Electrolyte Homeostasis in Chronic Idiopathic and Opioid-induced Constipation
por: Rao, Satish S.C., et al.
Publicado: (2021)

Lubiprostone: a novel treatment for chronic constipation
por: Lacy, Brian E, et al.
Publicado: (2008)

The Cost Effectiveness of Lubiprostone in Chronic Idiopathic Constipation
por: Pennington, Becky, et al.
Publicado: (2018)

A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly
por: Gras-Miralles, Beatriz, et al.
Publicado: (2013)

Lubiprostone for the Treatment of Adult Women with Irritable Bowel Syndrome with Constipation
por: Soubra, Mahmoud, et al.
Publicado: (2012)

Lubiprostone for the Treatment of Clozapine-Induced Constipation: A Case Series
por: Torrico, Tyler J, et al.
Publicado: (2022)

A Randomized, Placebo-Controlled Trial of Lubiprostone for Opioid-Induced Constipation in Chronic Noncancer Pain
por: Jamal, M Mazen, et al.
Publicado: (2015)

Factors associated with long-term efficacy of lubiprostone for chronic constipation
por: Morise, Takashi, et al.
Publicado: (2023)

Capsule and Sprinkle Formulations of Lubiprostone Are Not Biologically Similar in Patients with Functional Constipation
por: Adams, Atoya, et al.
Publicado: (2021)

Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome
por: Lunsford, Tisha N, et al.
Publicado: (2010)

Pharmacotherapy patterns in patients with chronic idiopathic constipation beginning treatment with linaclotide or lubiprostone in the United States
por: Nag, Arpita, et al.
Publicado: (2020)

Possible Effect of Concomitant Prokinetics and Herbal Medicines against Nausea in Patients Taking Lubiprostone
por: Yamamoto, Takatsugu, et al.
Publicado: (2017)

Safety of Lubiprostone in Pediatric Patients With Functional Constipation: A Nonrandomized, Open-Label Trial
por: Hussain, Sunny Z., et al.
Publicado: (2021)

Lubiprostone in the treatment of chronic idiopathic constipation: an update on health-related quality of life and patient-reported outcomes
por: Hayat, Maham, et al.
Publicado: (2019)

Effectiveness and safety of lubiprostone after switching from stimulant laxatives in elderly patients with chronic constipation
por: Maruyama, Masaki, et al.
Publicado: (2023)

Stimulation of Mucin, Mucus, and Viscosity during Lubiprostone in Patients with Chronic Constipation may Potentially Lead to Increase of Lubrication
por: Majewski, Marek, et al.
Publicado: (2014)

Effect of Lubiprostone on Urinary Protein Excretion: A Report of Two IgA Nephropathy Patients with Chronic Constipation
por: Takeshita, Mitsuhide, et al.
Publicado: (2019)

Role of Lubiprostone on Gastrointestinal Motility
por: Jun, Jae Yeoul
Publicado: (2013)

Clubbed Digits Presumably Caused by Lubiprostone
por: Kawamoto, Ryuichi, et al.
Publicado: (2021)

Long-Term Safety and Effectiveness of Lubiprostone, a Chloride Channel (ClC-2) Activator, in Patients with Chronic Idiopathic Constipation
por: Lembo, Anthony J., et al.
Publicado: (2011)

The Role of Food in the Treatment of Bowel Disorders: Focus on Irritable Bowel Syndrome and Functional Constipation
por: Singh, Prashant, et al.
Publicado: (2022)

Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation
por: Eswaran, Shanti, et al.
Publicado: (2014)

Lubiprostone Stimulates Duodenal Bicarbonate Secretion in Rats
por: Mizumori, Misa, et al.
Publicado: (2009)

Lubiprostone stimulates small intestinal mucin release
por: De Lisle, Robert C
Publicado: (2012)

Lubiprostone ameliorates the cystic fibrosis mouse intestinal phenotype
por: De Lisle, Robert C, et al.
Publicado: (2010)

Polyethylene Glycol 3350 in the Treatment of Chronic Idiopathic Constipation: Post hoc Analysis Using FDA Endpoints
por: Menees, Stacy B., et al.
Publicado: (2022)

Lubiprostone plus polyethylene glycol electrolyte lavage solution (PEG-ELS) versus PEG-ELS for bowel preparation in chronic constipation: a randomized controlled trial
por: Tangvoraphonkchai, K., et al.
Publicado: (2023)

Lower and Upper Gastrointestinal Symptoms Differ Between Individuals With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
por: Shah, Eric D, et al.
Publicado: (2018)

Pharmacologic, Dietary, and Psychological Treatments for Irritable Bowel Syndrome With Constipation: Cost Utility Analysis
por: Shah, Eric D., et al.
Publicado: (2021)

A meta-analysis of randomized controlled trials of the addition of lubiprostone to bowel preparation before colonoscopy
por: Li, Peng, et al.
Publicado: (2020)

Effects of Lubiprostone on Pacemaker Activity of Interstitial Cells of Cajal from the Mouse Colon
por: Jiao, Han-Yi, et al.
Publicado: (2014)

The Spectrum of Constipation-Predominant Irritable Bowel Syndrome and Chronic Idiopathic Constipation: US Survey Assessing Symptoms, Care Seeking, and Disease Burden
por: Heidelbaugh, Joel J, et al.
Publicado: (2015)

Gastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatment
por: Cryer, Byron, et al.
Publicado: (2014)

Psychotropics, Antidepressants, and Visceral Analgesics in Functional Gastrointestinal Disorders
por: Törnblom, Hans, et al.
Publicado: (2018)

Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial
por: Chey, William D, et al.
Publicado: (2017)

Development and Validation of a Nausea Severity Scale for Assessment of Nausea in Children with Abdominal Pain-Related Functional Gastrointestinal Disorders
por: Russell, Alexandra C., et al.
Publicado: (2018)

A comparison of linaclotide and lubiprostone dosing regimens on ion transport responses in human colonic mucosa
por: Kang, Sang Bum, et al.
Publicado: (2015)

Influence of Probiotics in Prevention and Treatment of Patients Who Undergo Chemotherapy or/and Radiotherapy and Suffer from Mucositis, Diarrhoea, Constipation, Nausea and Vomiting
por: Garczyk, Aleksandra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l4deavttvkfk6n2sccaafsmuqj